Additionally, a significant downregulation of PHLDA1 in primary human breast cancer was found by immunohistochemical staining and PHLDA1 was significantly less expressed in ErbB2-negative tumors as compared with ErbB2-positive tumors, where PHLDA1 was expressed abundantly. This evidence concerns the gene ERBB2 and breast carcinoma.